NovoCure Reveals Cybersecurity Breach Exposing Patient Data
NVCR sits 80% above its 52-week low of $9.82.
Summary
NovoCure reported a cybersecurity incident involving unauthorized access to patient and employee data. The company says operations were not affected and it does not expect a material financial impact, but the investigation is ongoing.
Key Events · Legal and Risk Events · NVCR
-
Cybersecurity Breach Disclosed
Unauthorized access to information systems was detected in mid-August 2026, exposing internal patient ID numbers for over 1,400 U.S. patients and identifying information for fewer than 50 others.
-
No Operational Impact
No access to medical treatment devices was obtained, and all systems remain fully functional. The company does not currently expect a material financial impact.
-
Investigation Ongoing
Independent cybersecurity forensic experts are assisting with the investigation, and the company will make required regulatory and legal notifications, including to impacted patients.
-
Potential Future Amendment
If the company later determines the incident will have a material impact, it will file an amendment under Item 1.05 within four business days of that determination.
Analysis · NVCR · Industrial Applications And Services
Unauthorized access to NovoCure's information systems exposed internal patient ID numbers for over 1,400 U.S. patients and identifying information for fewer than 50 others. The company states no medical devices were compromised and systems remain fully functional, and it does not currently expect a material financial impact. However, the breach involves sensitive patient data, which carries regulatory, legal, and reputational risk for a medical device company, and the company is still investigating the full scope.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 29.9% of the 1591 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.24%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, NVCR was trading at $17.70 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.1B. The 52-week trading range was $9.82 to $21.45. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.